Health Condition 1: O04- Complications following (induced)termination of pregnancy
Conditions
Interventions
Intervention1: Medical termination of pregnancy in second trimester by Mifepristone and Misoprostol: tab Mifepristone 200mg oral after 48hrs tab Misoprostol 400mcg per vagina every 3 hours to maximum
Sponsors
Dr Geetha Shree B
Eligibility
Inclusion criteria
Inclusion criteria: Pregnant women between 18 to 45years seeking termination of pregnancy between 13-24 weeks of gestation fulfilling the prerequisites of Medical Termination of Pregnancy act 1971 and its amendments in 2021
Exclusion criteria
Exclusion criteria: Women with hemoglobin less than 8mg/dl Multiple Pregnancy Women with coagulation disorder Women with other medical disorders Incomplete abortion Patient with per vaginal leak Low lying placenta Patient with more than 1 previous cesarean section Intrauterine death Septic abortion Molar pregnancy Prior allergy to any of the drugs used in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the safety and efficacy of Mifepristone and Misoprostol versus dinoprostone gel with Misoprostol in second trimester pregnancy termination; in terms of rate of complete abortion and induced abortion intervalTimepoint: One year | — |
Secondary
| Measure | Time frame |
|---|---|
| To compare & analyse need for surgical evacuation, uterine rupture, blood loss , sepsis, pain & need for analgesia between the study groupTimepoint: One year | — |
Countries
India
Contacts
Public ContactDr Sunita Kittali
Belagavi institute of medical sciences
Outcome results
None listed